<p>Absolut distribution of positive (1–3), rather neutral (4a) and negative (4b) outcome within the study parameter “function of intervention”. Chi<sup>2</sup>-Test, P<0.001.</p><p>Contingency table of absolute outcome distribution within interventions in main focus of a study or comparison interventions.</p
Distribution of baseline characteristics between outcome categories, and their differences.</p
<p>Note: The upper table shows generic information from which <i>P</i> is calculated, where A, B, C ...
The contingency table of baseline versus follow-up group membership among females (N = 11830).</p
<p>Relative distribution of positive (1–3), rather neutral (4a) and negative (4b) outcome within the...
<p>Relative distribution of positive (1–3), rather neutral (4a) and negative (4b) outcome within the...
<p>Contingency table of the distribution of citations from three different classifications of review...
The proportions of each clinical outcome in the different follow-up interval groups.</p
<p>ID: injected dose; true positive rate: 0.92 (23 out of 25); false positive rate: 0.01 (1 out of 8...
<p>Interventions compared, study objectives and main study conclusions of included studies.</p
<p>δ negative number favors drug 1, positive number favors drug 2 in these comparisons.</p><p>Compar...
<p>N: number of samples; SD: standard deviation.</p><p>Distribution of the clinical outcomes of ante...
Biostatistics is an essential part when making clinical decisions. Applications of 2×2 contingency t...
Descriptive statistics on outcome measures separated by treatment groups and times of testing (T1 = ...
<p>Note that absolute values are not comparable between testing methods. Asterisks indicate signific...
<p>Contingency table of the combined use of ‘metric’ and ‘interval scale’ by paradigm.</p
Distribution of baseline characteristics between outcome categories, and their differences.</p
<p>Note: The upper table shows generic information from which <i>P</i> is calculated, where A, B, C ...
The contingency table of baseline versus follow-up group membership among females (N = 11830).</p
<p>Relative distribution of positive (1–3), rather neutral (4a) and negative (4b) outcome within the...
<p>Relative distribution of positive (1–3), rather neutral (4a) and negative (4b) outcome within the...
<p>Contingency table of the distribution of citations from three different classifications of review...
The proportions of each clinical outcome in the different follow-up interval groups.</p
<p>ID: injected dose; true positive rate: 0.92 (23 out of 25); false positive rate: 0.01 (1 out of 8...
<p>Interventions compared, study objectives and main study conclusions of included studies.</p
<p>δ negative number favors drug 1, positive number favors drug 2 in these comparisons.</p><p>Compar...
<p>N: number of samples; SD: standard deviation.</p><p>Distribution of the clinical outcomes of ante...
Biostatistics is an essential part when making clinical decisions. Applications of 2×2 contingency t...
Descriptive statistics on outcome measures separated by treatment groups and times of testing (T1 = ...
<p>Note that absolute values are not comparable between testing methods. Asterisks indicate signific...
<p>Contingency table of the combined use of ‘metric’ and ‘interval scale’ by paradigm.</p
Distribution of baseline characteristics between outcome categories, and their differences.</p
<p>Note: The upper table shows generic information from which <i>P</i> is calculated, where A, B, C ...
The contingency table of baseline versus follow-up group membership among females (N = 11830).</p